These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7708983)

  • 41. Minocycline-induced hepatitis.
    Nietsch HH; Libman BS; Pansze TW; Eicher JN; Reeves JR; Krawitt EL
    Am J Gastroenterol; 2000 Oct; 95(10):2993-5. PubMed ID: 11051393
    [No Abstract]   [Full Text] [Related]  

  • 42. Minocycline in neurological diseases.
    Bandini F
    Lancet Neurol; 2005 Mar; 4(3):138-9; discussion 139. PubMed ID: 15721822
    [No Abstract]   [Full Text] [Related]  

  • 43. Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris.
    Schrodt BJ; Kulp-Shorten CL; Callen JP
    South Med J; 1999 May; 92(5):502-4. PubMed ID: 10342897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physician, Beware! Drug Fever Without Skin Rashes Can Be Caused by Minocycline.
    Gu W; Shi D; Mi N; Pang X; Liu W
    J Investig Allergol Clin Immunol; 2017; 27(4):268-269. PubMed ID: 28731416
    [No Abstract]   [Full Text] [Related]  

  • 45. Minocycline therapy in acne vulgaris.
    Cullen SI; Cohan RH
    Cutis; 1976 Jun; 17(6):1208-10, 1214. PubMed ID: 138560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minocycline-induced pneumonitis with bilateral hilar lymphadenopathy and pleural effusion.
    Bando T; Fujimura M; Noda Y; Hirose J; Ohta G; Matsuda T
    Intern Med; 1994 Mar; 33(3):177-9. PubMed ID: 8061398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe minocycline-induced eosinophilic pneumonia: extrapulmonary manifestations and the use of in vitro immunoassays.
    Bentur L; Bar-Kana Y; Livni E; Finkelstein R; Ben-Izhak O; Keidar S; Bentur Y
    Ann Pharmacother; 1997 Jun; 31(6):733-5. PubMed ID: 9184714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pulmonary eosinophilia with excavated opacities possibly induced by salazosulfapyridine].
    Khaleq K; Trombati N; Aichane A; Bahlaoui A; Bouayad Z
    Rev Mal Respir; 2001 Dec; 18(6 Pt 1):667-8. PubMed ID: 11924192
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of low-dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris.
    Monk BE; Almeyda JA; Caldwell IW; Green B; Pelta D; Leonard J; Du Vivier A; Johnson K; Tolowinska I
    Clin Exp Dermatol; 1987 Sep; 12(5):319-22. PubMed ID: 2965628
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug hypersensitivity syndrome caused by minocycline.
    Tsuruta D; Someda Y; Sowa J; Kobayashi H; Ishii M
    J Cutan Med Surg; 2006; 10(3):131-5. PubMed ID: 17241589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracranial hypertension and minocycline.
    Shiri J; Amichai B
    Ann Intern Med; 1997 Jul; 127(2):168. PubMed ID: 9230019
    [No Abstract]   [Full Text] [Related]  

  • 52. A clinical study of minocycline-induced pneumonitis.
    Toyoshima M; Sato A; Hayakawa H; Taniguchi M; Imokawa S; Chida K
    Intern Med; 1996 Mar; 35(3):176-9. PubMed ID: 8785448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudo-tumor cerebri and acne.
    Delaney RA; Narayanaswamy TR; Wee D
    Mil Med; 1990 Oct; 155(10):511. PubMed ID: 2146526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extended-release minocycline (Solodyn) for acne.
    Med Lett Drugs Ther; 2006 Nov; 48(1248):95-6. PubMed ID: 17106435
    [No Abstract]   [Full Text] [Related]  

  • 55. Minocycline in acne vulgaris: benefits and risks.
    Ochsendorf F
    Am J Clin Dermatol; 2010; 11(5):327-41. PubMed ID: 20642295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minocycline and generalized cutaneous pigmentation.
    Simons JJ; Morales A
    J Am Acad Dermatol; 1980 Sep; 3(3):244-7. PubMed ID: 6450226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minocycline for acne.
    Ferner RE; Moss C
    BMJ; 1996 Jan; 312(7024):138. PubMed ID: 8563527
    [No Abstract]   [Full Text] [Related]  

  • 58. Is serum sickness an uncommon adverse effect of minocycline treatment?
    Malakar S; Dhar S; Shah Malakar R
    Arch Dermatol; 2001 Jan; 137(1):100-1. PubMed ID: 11176679
    [No Abstract]   [Full Text] [Related]  

  • 59. Interstitial nephritis, hepatic failure, and systemic eosinophilia after minocycline treatment.
    Kiessling S; Forrest K; Moscow J; Gewirtz A; Jackson E; Roszman T; Goebel J
    Am J Kidney Dis; 2001 Dec; 38(6):E36. PubMed ID: 11728996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Minocycline-induced lupus-like disease].
    Leydet H; Armingeat T; Pham T; Lafforgue P
    Rev Med Interne; 2006 Jan; 27(1):72-5. PubMed ID: 16236387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.